• Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Featured Page 272

Featured

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Pα+ Psychedelic Bulletin #201: Dispatches from Prague and London; Texas Becomes Leader in Ibogaine Research as Governor Signs $50M Match-Funding Bill; High-Dose LSD Shows...

May 2025 Psychedelic Patent Update: Gilgamesh Broadens Moat Around Lead Candidate Following Positive Phase 2a Readout; Lykos Publishes Further Continuation Applications; Reconnect Joins Crowded...

Win 10 Groundbreaking Psychedelic Books – Our Giveaway with Inner Traditions!

Psychedelic Playhouse by District216

Psychedelic Bulletin #200: Can Czechia Deliver on Psilocybin Access? A Closer Look at ‘atai Beckley’; Q1’25 Psychedelic Lobbying Update; Catching Up with the Class...

Should You Listen to Music During Psychedelic Treatments? How Sounds Impact...

Interview With Christi Myers

Interview With Ronan Levy

Will the Biden Administration Embrace Federal Psychedelic Reform?

Center for Psychedelic Medicine Established at NYU Langone Health

So, You Want to Take Ibogaine: Here’s What You Need to...

Red Light Holland Announces Closing of $11.6 Million Bought Deal Financing

Entheon Biomedical Corp. Provides Update on Subsidiary, HaluGen Life Sciences

Tryp Therapeutics to Present at the Stifel GMP Healthcare Conference

Mydecine Announces Exclusive Partnership and Increased Capabilities with Applied Pharmaceutical Innovation...

1...271272273...289Page 272 of 289

EDITOR PICKS

Pα+ Psychedelic Bulletin #201: Dispatches from Prague and London; Texas Becomes...

May 2025 Psychedelic Patent Update: Gilgamesh Broadens Moat Around Lead Candidate...

Win 10 Groundbreaking Psychedelic Books – Our Giveaway with Inner Traditions!

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    ©